A 36-year- old man comes for regular follow up. An erythropoiesis-stimulating agent was prescribed for his low hemoglobin level due chronic kidney disease 3 months ago. His hemoglobin level today is 10.5 mg/dL . Which of the following complications is most likely to be seen with the agent used to treat this patient's anemia?

Question

Quizplus · Accepted Answer

Eductional Objective: Erythropoiesis-stimulating agents (ESAs) can substantially improve anemia symptoms, avoiding the need for blood transfusions in chronic kidney disease and dialysis patients.  However, ESAs are associated with increased risk for hypertension and thromboembolic events.

A 36-Year- Old Man Comes for Regular Follow Up